Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Innocan Pharma Announces Private Placement of Units (PR Newswire) +++ INNOCAN Aktie +3,45%

ANI PHARMA Aktie

 >ANI PHARMA Aktienkurs 
61 EUR    (TradegateBSX)
Ask: 61.5 EUR / 49 Stück
Bid: 60.5 EUR / 51 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
ANI PHARMA Aktie über LYNX handeln
>ANI PHARMA Performance
1 Woche: -4,3%
1 Monat: -9,7%
3 Monate: -14,2%
6 Monate: -4,7%
1 Jahr: -28,2%
laufendes Jahr: -13,6%
>ANI PHARMA Aktie
Name:  ANI PHARMACEUT. DL-,0001
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US00182C1036 / A1W15D
Symbol/ Ticker:  BSFA (Frankfurt) / ANIP (NASDAQ)
Kürzel:  FRA:BSFA, ETR:BSFA, BSFA:GR, NASDAQ:ANIP
Index:  -
Profil:  ANI Pharmaceuticals, Inc. is a biopharmaceutical company that develops, manufactures, and commercializes branded, generic, and specialty prescription medicines. ANI Pharmaceuticals focuses on three main areas: Rare Disease, Generics, and Established ..
>Volltext..
Marktkapitalisierung:  1409.01 Mio. EUR
Unternehmenswert:  1614.62 Mio. EUR
Umsatz:  842.54 Mio. EUR
EBITDA:  186.27 Mio. EUR
Nettogewinn:  86.07 Mio. EUR
Gewinn je Aktie:  4.14 EUR
Schulden:  525.73 Mio. EUR
Liquide Mittel:  310.23 Mio. EUR
Operativer Cashflow:  163.16 Mio. EUR
Bargeldquote:  1.33
Umsatzwachstum:  35.02%
Gewinnwachstum:  -
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel 4 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 764.718 Euro.
Suchwörter:  ANI PHARMA, ANI PHARMACEUTICALS
Letzte Datenerhebung:  10.09.26
>ANI PHARMA Kennzahlen
Aktien/ Unternehmen:
Aktien: 22.96 Mio. St.
Frei handelbar: 87.87%
Rückkaufquote: 0.6%
Mitarbeiter: 970
Umsatz/Mitarb.: 0.78 Mio. EUR
Analysten:
Analystenrating: Strong buy
Kursziel: 47.68%
Bewertung:
KGV: 15.65
KGV lG: 7.95
KUV: 1.76
KBV: 2.79
PEG-Ratio: -
EV/EBITDA: 8.67
Rentabilität:
Bruttomarge: 51.63%
Gewinnmarge: 10.22%
Operative Marge: 13.34%
Managementeffizenz:
Gesamtkaprendite: 7.05%
Eigenkaprendite: 19.33%
>ANI PHARMA Peer Group
Gesundheit, Augenmedizin/ Sehhilfen, Rheuma- Behandlung, Neurologische Erkrankungen/ Schlaganfälle, Lungen- & Atemwegserkrankungen/ -behandlung
 
02.09.26 - 05:01
Insiderhandel: SVP & CFO verkauft Aktien von ANI Pharmaceuticals im Wert von 207480 USD (Insiderkauf)
 
Carey, Stephen P. - Vorstand - Tag der Transaktion: 2026-08-31...
27.08.26 - 02:01
Insiderhandel: PRESIDENT & CEO verkauft Aktien von ANI Pharmaceuticals im Wert von 401220 USD (Insiderkauf)
 
Lalwani, Nikhil - Vorstand - Tag der Transaktion: 2026-08-25...
14.08.26 - 20:30
ANIP′s Cortrophin Guidance Cut Raises the Bar for Second-Half Growth (Zacks)
 
Cortrophin guidance cuts put more pressure on ANI Pharmaceuticals' second-half execution as the drug must deliver a sharper growth ramp....
14.08.26 - 20:30
Should You Buy ANIP as Low Valuation Meets Cortrophin Execution Risk? (Zacks)
 
ANI Pharmaceuticals' low valuation and strong 2026 growth outlook face a key test as Cortrophin execution risk rises....
14.08.26 - 15:24
ANI Pharmaceuticals (ANIP) Q2 2026 Earnings Call Transcript (Fool)
 
Rare disease revenue surged 43.5% as Cortrophin Gel sales accelerated across key specialties....
14.08.26 - 01:01
Insiderhandel: SR. VP, GENERAL COUNSEL & SEC. verkauft Aktien von ANI Pharmaceuticals im Wert von 37740 USD (Insiderkauf)
 
Cook, Meredith - Vorstand - Tag der Transaktion: 2026-08-13...
12.08.26 - 05:01
Insiderhandel: SVP, GENERICS verkauft Aktien von ANI Pharmaceuticals im Wert von 243474 USD (Insiderkauf)
 
Gutwerg, Ori - Vorstand - Tag der Transaktion: 2026-08-10...
10.08.26 - 20:30
ANIP Tops Q2 Earnings, Stock Down on Cortrophin Sales View Cut (Zacks)
 
ANI Pharmaceuticals tops Q2 earnings and sales estimates, but shares fall as the company cuts its 2026 Cortrophin Gel revenue outlook....
07.08.26 - 16:00
ANI Pharmaceuticals (ANIP) Q2 Earnings and Revenues Beat Estimates (Zacks)
 
ANI (ANIP) delivered earnings and revenue surprises of +9.95% and +1.26%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?...
07.08.26 - 12:57
ANI Pharmaceuticals Non-GAAP EPS of $2.21 beats by $0.17, revenue of $266.04M beats by $5.91M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
07.08.26 - 12:54
ANI Pharmaceuticals Reports Record Second Quarter 2026 Financial Results (GlobeNewswire EN)
 
PRINCETON, N.J., Aug. 07, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced financial results and business highlights for the second quarter ended June 30, 2026....
06.08.26 - 15:30
ANI Pharmaceuticals Q2 2026 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
31.07.26 - 17:30
ANI Pharmaceuticals (ANIP) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
 
ANI (ANIP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....
31.07.26 - 02:01
Insiderhandel: SVP & CFO verkauft Aktien von ANI Pharmaceuticals im Wert von 231876 USD (Insiderkauf)
 
Carey, Stephen P. - Vorstand - Tag der Transaktion: 2026-07-29...
24.07.26 - 12:54
ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET (GlobeNewswire EN)
 
PRINCETON, N.J., July 24, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that the Company will release its second quarter 2026 financial results on Friday, August 7, 2026, at 8:00 a.m. ET....
16.07.26 - 22:36
ANI Pharmaceuticals Announces Intent to Appeal Rulings in CG Oncology Matter (GlobeNewswire EN)
 
PRINCETON, N.J., July 16, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that Judge Sheldon K. Rennie, on July 16, 2026, denied ANI's post-trial motions for a new trial and judgment as a matter of law. ANI intends to appeal to the Delaware Supreme Court and continue to seek to recover the value of the assets it sold to CG Oncology under the 2010 Agreement between the parties....
15.07.26 - 01:01
Insiderhandel: SR. VP, GENERAL COUNSEL & SEC. verkauft Aktien von ANI Pharmaceuticals im Wert von 40920 USD (Insiderkauf)
 
Cook, Meredith - Vorstand - Tag der Transaktion: 2026-07-13...
13.07.26 - 12:54
ANI Pharmaceuticals Announces Positive Six-Month Topline Data from the Phase 4 Open-Label, Single-Arm SYNCHRONICITY Trial Evaluating Fluocinolone Acetonide Intravitreal Implant in Patients with Chronic Non-Infectious Uveitis (GlobeNewswire EN)
 
PRINCETON, N.J., July 13, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced positive topline data from its Phase 4, open-label, single-arm SYNCHRONICITY clinical trial of Fluocinolone Acetonide Intravitreal Implant in patients with chronic non-infectious uveitis affecting the posterior segment of the eye (chronic NIU-PS)....
13.07.26 - 02:48
ANI Pharmaceuticals′ CFO Sold $285,000 in Stock After a 32% Run (Fool)
 
Carey exercised vested options under a pre-established Rule 10b5-1 trading plan adopted in March, retaining 177,543 directly held shares....
10.07.26 - 00:24
ANI Pharmaceuticals CFO Sells $240,000 in Stock After a 42% Cortrophin Surge (Fool)
 
This specialty pharma company, known for its branded and generic drug portfolio, just reported a notable insider sale in the latest filing....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Die Überalterung ist vor allem ein Problem der leitenden Gremien. - Dr. Gerhard Kocher
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!